AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of AbbVie Inc. (ABBV) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on Apr 17, 2022.
The trade happened on Mar 17, 2022, 31 days before it was made public.
ABBV has moved +65.8% since the trade date, from $158.59 to $262.90 (Oct 2, 2026 close).
- Traded
- Mar 17, 2022
- Disclosed
- Apr 17, 2022
- Filing delay
- 31 days
- Price since
- +65.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (51)
- BuyAAPL$1K-$15KApr 17, 2022
- SellAAPL$1K-$15KApr 17, 2022
- BuyABBV$1K-$15KApr 17, 2022
- BuyAMGN$1K-$15KApr 17, 2022
- SellAPD$1K-$15KApr 17, 2022
- SellBIIB$1K-$15KApr 17, 2022
- BuyBX$1K-$15KApr 17, 2022
- SellCCXI$1K-$15KApr 17, 2022
- SellCSTL$1K-$15KApr 17, 2022
- BuyCTSH$1K-$15KApr 17, 2022
- BuyCTSH$1K-$15KApr 17, 2022
- SellCVET$1K-$15KApr 17, 2022
- SellCVNA$1K-$15KApr 17, 2022
- SellDAVA$1K-$15KApr 17, 2022
- SellDAVA$1K-$15KApr 17, 2022
- SellETSY$1K-$15KApr 17, 2022
- BuyFIS$1K-$15KApr 17, 2022
- SellGBCI$1K-$15KApr 17, 2022
- BuyGOOG$1K-$15KApr 17, 2022
- SellHUBS$1K-$15KApr 17, 2022
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.